MATTINGLY MARTIN A
Insider CIK 1265782 · TCON Director · OGXI Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TCON Tracon Pharmaceuticals, In | A Award deriv | 2023-04-19 | 2023-04-21 | 18,000 | — | $0 | 18,000 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | A Award deriv | 2022-06-14 | 2022-06-16 | 15,750 | — | $0 | 15,750 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2022-05-31 | 2022-06-01 | 4,400 | — | $0 | 4,400 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | A Award deriv | 2021-06-10 | 2021-06-24 | 10,500 | — | $0 | 10,500 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2021-05-11 | 2021-05-13 | 3,750 | — | $0 | 3,750 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | A Award deriv | 2020-06-10 | 2020-06-16 | 4,500 | — | $0 | 4,500 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2020-05-12 | 2020-05-14 | 22,000 | — | $0 | 22,000 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | A Award deriv | 2019-06-13 | 2019-06-17 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2019-05-14 | 2019-05-15 | 7,000 | — | $0 | 7,000 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2018-09-20 | 2018-09-21 | 12,000 | — | $0 | 12,000 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | A Award deriv | 2018-06-13 | 2018-06-13 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2017-08-01 | 2017-08-03 | 11,000 | — | $0 | 11,000 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2017-08-01 | 2017-09-12 | 11,000 | — | $0 | 11,000 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | A Award deriv | 2017-06-15 | 2017-06-15 | 15,000 | — | $0 | 15,000 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | A Award | 2016-06-01 | 2016-06-02 | 7,500 | — | $0 | 7,500 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2016-05-26 | 2016-05-27 | 22,500 | — | $0 | 22,500 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2016-05-20 | 2016-05-24 | 2,500 | — | $0 | 0 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise | 2016-05-20 | 2016-05-24 | 2,500 | — | $0 | 10,500 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | A Award deriv | 2015-07-23 | 2015-07-24 | 9,517 | — | $0 | 9,517 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | A Award deriv | 2015-07-23 | 2015-07-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2015-05-21 | 2015-05-22 | 2,500 | — | $0 | 2,500 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2015-05-21 | 2015-05-22 | 5,000 | — | $0 | 5,000 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2015-05-20 | 2015-05-22 | 2,500 | — | $0 | 0 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise | 2015-05-20 | 2015-05-22 | 2,500 | — | $0 | 8,000 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | A Award deriv | 2015-03-04 | 2015-03-05 | 15,483 | — | $0 | 15,483 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2014-06-05 | 2014-06-09 | 5,000 | — | $0 | 5,000 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2014-06-05 | 2014-06-09 | 2,500 | — | $0 | 2,500 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2014-06-05 | 2014-06-09 | 2,500 | — | $0 | 0 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise | 2014-06-05 | 2014-06-09 | 2,500 | — | $0 | 5,500 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2013-05-24 | 2013-05-28 | 5,000 | — | $0 | 5,000 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2013-05-24 | 2013-05-28 | 2,500 | — | $0 | 2,500 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2013-05-23 | 2013-05-28 | 2,000 | — | $0 | 0 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise | 2013-05-23 | 2013-05-28 | 2,000 | $10.64 | $21.3K | 3,000 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | P Buy | 2012-06-01 | 2012-06-04 | 1,000 | $12.46 | $12.5K | 1,000 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2012-05-31 | 2012-06-04 | 4,000 | — | $0 | 4,000 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2012-05-31 | 2012-06-04 | 2,000 | — | $0 | 2,000 | SEC↗ |